Jonathan Couchman - Jan 16, 2025 Form 4 Insider Report for ENZO BIOCHEM INC (ENZ)

Role: Director
Signature: /s/ Jon Couchman
Stock symbol: ENZ
Transactions as of: Jan 16, 2025
Transactions value $: $0
Form type: 4
Date filed: 1/17/2025, 04:44 PM
Previous filing: Dec 2, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ENZ	Common Stock	Award	$0	+143K		$0.00	143K	Jan 16, 2025	Direct	F1
holding	ENZ	Common Stock						130K	Jan 16, 2025	By Xstelos Holdings, Inc.	F2
holding	ENZ	Common Stock						130K	Jan 16, 2025	By Xstelos Holdings, Inc.	F3
holding	ENZ	Common Stock						277K	Jan 16, 2025	In retirement accounts	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted Restricted Stock Units that will fully vest upon the earlier of: (i) the first anniversary of the grant date (i.e., January 16, 2026), or (ii) a change of control event.
F2	Shares are owned by Xstelos Holdings, Inc., of which the Reporting Person is the sole officer and controlling person. He controls a majority of the shares of Xstelos Holdings, Inc. through shares held in his personal Roth IRA retirement account and through shares held by Couchman Investments LP, a family investment fund, which he controls and which is owned by him and by a trust for the benefit of his children, of which he is the investment manager. The Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein, except to the extent of his pecuniary interest therein, and the filing of this Form 3 shall not be construed as an admission that the Reporting Person is a beneficial owner of the securities of the Issuer reported herein.
F3	Shares are owned by Myrexis, Inc., of which the Reporting Person is the sole officer and controlling person. Myrexis, Inc. is controlled by Xstelos Holdings, Inc. The Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein, except to the extent of his pecuniary interest therein, and the filing of this Form 3 shall not be construed as an admission that the Reporting Person is a beneficial owner of the securities of the Issuer reported herein.
F4	227,237 shares are held in the Reporting Person's personal SEP-IRA retirement account and 50,000 shares are held in the Reporting Person's personal 401(k) retirement account.